Companies / BOC Sciences / Tilvestamab
BOC Sciences

Tilvestamab | BOC Sciences

Tilvestamab is a humanized anti-AXL function blocking monoclonal antibody. Tilvestamab inhibited AXL activation induced by Gas6 stimulation in vitro. Tilvestamab inhibited the progression of tumors induced by the orthotopically implanted 786-0 renal cell carcinoma cells.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
  • See More